Atea Pharmaceuticals (AVIR) Q2 2025 Earnings

May 12Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.66
-0.54
-0.41
-0.29

Details

Expected EPS
-0.503333
Actual EPS
-0.4
Surprise EPS
0.1
Surprise Percent
+20.53%

Description

⁨Atea Pharmaceuticals⁩ (⁦AVIR⁩) has reported earnings of ⁦-0.4⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts